Poxel S.A. (OTCMKTS:PXXLF) Short Interest Update

Poxel S.A. (OTCMKTS:PXXLF) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totalling 2,000 shares, an increase of 1,900.0% from the July 15th total of 100 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Poxel Price Performance

Shares of PXXLF remained flat at $0.70 during trading hours on Monday. The business’s 50 day moving average is $0.70 and its 200-day moving average is $0.64. Poxel has a fifty-two week low of $0.55 and a fifty-two week high of $0.70.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.